End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
26.05 TWD | -3.16% | -1.70% | -15.70% |
Apr. 18 | Bioray Biotech Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Bioray Biotech Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
Sales 2022 | 191M 5.89M | Sales 2023 | 192M 5.93M | Capitalization | 930M 28.74M |
---|---|---|---|---|---|
Net income 2022 | - 0 | Net income 2023 | -11M -340K | EV / Sales 2022 | 4.53 x |
Net cash position 2022 | 38.16M 1.18M | Net cash position 2023 | 27.23M 842K | EV / Sales 2023 | 4.7 x |
P/E ratio 2022 |
1,678
x | P/E ratio 2023 |
-80.4
x | Employees | - |
Yield 2022 |
0.67% | Yield 2023 |
-
| Free-Float | 63.47% |
1 day | -3.16% | ||
1 week | -1.70% | ||
Current month | +9.00% | ||
1 month | +27.70% | ||
3 months | -7.13% | ||
6 months | -9.39% | ||
Current year | -15.70% |
Managers | Title | Age | Since |
---|---|---|---|
Chun Mei Lue
CEO | Chief Executive Officer | - | 17-10-29 |
Cheng Shun Kuo
DFI | Director of Finance/CFO | - | - |
Yue Chiu Lu
CTO | Chief Tech/Sci/R&D Officer | - | 19-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Po Wen Huang
BRD | Director/Board Member | - | 20-03-03 |
Chun Mei Lue
CEO | Chief Executive Officer | - | 17-10-29 |
Ching Wen Wang
BRD | Director/Board Member | - | 20-03-03 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-21 | 26.05 | -3.16% | 29,000 |
24-06-20 | 26.9 | +1.89% | 31,000 |
24-06-19 | 26.4 | +0.38% | 34,000 |
24-06-18 | 26.3 | +0.77% | 52,100 |
24-06-17 | 26.1 | -1.51% | 42,110 |
End-of-day quote Taipei Exchange, June 20, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-15.70% | 24.19M | |
+13.80% | 8.17B | |
+1.10% | 7.31B | |
-8.08% | 5.43B | |
-6.72% | 3.69B | |
-19.73% | 3.2B | |
-12.00% | 1.21B | |
-26.74% | 1.12B | |
-14.98% | 868M | |
+0.89% | 868M |
- Stock Market
- Equities
- 7561 Stock